North America HLA Typing Transplant Diagnostics Services Market_, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025

  • ID: 4587327
  • Report
  • Region: America, North America, United States
  • 100 pages
  • Data Bridge Market Research Private Limited
1 of 4

FEATURED COMPANIES

  • Admera Health
  • Bloodcenter of Wisconsin
  • Creative Biolabs and
  • Histogenetics LLC
  • NEW YORK blood center
  • Proimmune ltd.
  • MORE
North America HLA typing transplant diagnostics services is expected to register a healthy CAGR in the forecast period 2018 to 2025. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

The major factors contributing to the growth of the market includes factors such as technological advancements in HLA typing, increasing number of solid organ and stem cell transplantation procedures and increased research grants, funds, and public-private investments.

The key market players for North America HLA typing transplant diagnostics services are listed below:
  • Thermo Fisher Scientific Inc.
  • Proimmune ltd.
  • Laboratory Corporation Of America Holdings
  • Creative Biolabs and
  • Histogenetics LLC
  • THE UCLA immunogenetics center.
  • Admera Health
  • Quick Biology
  • NEW YORK blood center
  • The Sequencing Center
  • Bloodcenter of Wisconsin
  • Thermo Fisher Scientific Inc.
The market is further segmented into:
  • Technology
  • Technique
  • End-Users
The North America HLA typing transplant diagnostics services market is segmented on the basis of technology into polymerase chain reaction (PCR) and next-generation sequencing (NGS). In 2018, Polymerase Chain Reaction (PCR) is expected to dominate the hospital LIMS market with 52.0% market share growing at a CAGR of 8.6% in the forecast period 2018 to 2025. However, next-generation sequencing (NGS) segment is expected to grow at the highest CAGR in the forecast period.

The North America HLA typing transplant diagnostics services market is segmented on the basis of technique into PCR-SSP (Sequence-Specific Primer), PCR SSOP (Sequence-Specific Oligonucleotide) and PCR-SBT (Sequencing Based Typing). In 2018, PCR-SSP (Sequence-Specific Primer) is expected to dominate the market with highest market share and is growing at a healthy CAGR in the forecast period 2018 to 2025. However, PCR-SBT (Sequencing Based Typing) market segment is expected to grow at the highest CAGR in the forecast period.

The North America HLA typing transplant diagnostics services market is segmented on the basis of end-users into hospitals, transplant centers, specialty clinics and academic institutes. In 2018, on-premise hospital LIMS is expected to dominate the hospital LIMS market in the forecast period 2018 to 2025. However, hospitals market segment is expected to grow at the highest CAGR and is expected to reach USD 185.24 million in 2025.

Based on geography, the market is segmented into 3 geographical regions:
  • U.S.
  • Canada
  • Mexico
Covered in this report:

The report covers the present scenario and the growth prospects of the North America HLA typing transplant diagnostics services for 2018-2025. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Admera Health
  • Bloodcenter of Wisconsin
  • Creative Biolabs and
  • Histogenetics LLC
  • NEW YORK blood center
  • Proimmune ltd.
  • MORE
1. Introduction
1.1. Objectives Of The Study
1.2. Market Definition
1.3. Overview Of North America Hla Typing Transplant Diagnostics Services Market
1.4. Currency And Pricing
1.5. Limitation
1.6. Markets Covered

2. Market Segmentation
2.1. Markets Covered
2.2. Geographic Scope
2.3. Years Considered For The Study
2.4. Currency And Pricing
2.5. Research Methodology
2.6. Primary Interviews With Key Opinion Leaders
2.7. Secondary Sources
2.8. Assumptions

3. Market Overview
3.1. Drivers
3.1.1. Technological Advancements In Hla Typing
3.1.2. Increasing Number Of Solid Organ And Stem Cell Transplantation Procedures
3.1.3. Increased Research Grants, Funds, And Public-Private Investments
3.2. Restraints
3.2.1. Weak Reimbursements For Organ Donation And Transplantation Procedures
3.2.2. Expensive Ngs And Pcr-Based Devices
3.3. Opportunities
3.3.1. Rising Healthcare Infrastructure In Emerging Nations
3.4. Challenges
3.4.1. Significant Gap Between Number Of Organs Donated And Organs Required Annually
3.4.2. Lack Of Trained Staff

4. Executive Summary

5. Premium Insights

6. North America Hla Typing Transplant Diagnostics Services Market, By Technology
6.1. Overview
6.2. Next-Generation Sequencing (Ngs)
6.3. Polymerase Chain Reaction (Pcr)
6.3.1. Pcr Ssop (Sequence-Specific Oligonucleotide)
6.3.2. Pcr Ssp (Sequence-Specific Primer)
6.3.3. Pcr-Sbt (Sequencing Based Typing)

7. North America Hla Typing Transplant Diagnostics Services Market, By End-User
7.1. Overview
7.2. Specialty Clinics
7.3. Hospitals
7.4. Transplant Centers
7.5. Academic Institutes

8. North America Hla Typing Transplant Diagnostics Services Market, By Geography
8.1. North America
8.1.1. U.S.
8.1.2. Canada
8.1.3. Mexico

9. North America Hla Typing Transplant Diagnostics Services Market, Company Landscape
9.1. Company Share Analysis: North America

10. Company Profiles
10.1. Proimmune Ltd.
10.1.1. Company Overview
10.1.2. Proimmune Ltd.: Company Snapshot
10.1.3. Product Portfolio
10.1.4. Recent Developments
10.2. Creative Biolabs
10.2.1. Company Overview
10.2.2. Creative Biolabs: Company Snapshot
10.2.3. Product Portfolio
10.2.4. Recent Developments
10.3. Histogenetics Llc
10.3.1. Company Overview
10.3.2. Histogenetics Llc: Company Snapshot
10.3.3. Product Portfolio
10.3.4. Recent Developments
10.4. The Ucla Immunogenetics Center
10.4.1. Company Overview
10.4.2. The Ucla Immunogenetics Center: Company Snapshot
10.4.3. Product Portfolio
10.4.4. Recent Developments
10.5. Admera Health
10.5.1. Company Overview
10.5.2. Admera Health: Company Snapshot
10.5.3. Product Portfolio
10.5.4. Recent Developments
10.6. Quick Biology
10.6.1. Company Overview
10.6.2. Quick Biology: Company Snapshot
10.6.3. Product Portfolio
10.6.4. Recent Developments
10.7. New York Blood Center
10.7.1. Company Overview
10.7.2. New York Blood Center: Company Snapshot
10.7.3. Product Portfolio
10.7.4. Recent Developments
10.8. The Sequencing Center
10.8.1. Company Overview
10.8.2. The Sequencing Center: Company Snapshot
10.8.3. Product Portfolio
10.8.4. Recent Developments
10.9. Bloodcenter Of Wisconsin
10.9.1. Company Overview
10.9.2. Bloodcenter Of Wisconsin: Company Snapshot
10.9.3. Product Portfolio
10.9.4. Recent Developments
10.10. Laboratory Corporation Of America Holdings
10.10.1. Company Overview
10.10.2. Laboratory Corporation Of America Holdings: Revenue Analysis
10.10.3. Product Portfolio
10.10.4. Recent Developments
10.11. Thermo Fisher Scientific Inc.
10.11.1. Company Overview
10.11.2. Thermo Fisher Scientific Inc. :Revenue Analysis
10.11.3. Product Portfolio
10.11.4. Recent Developments

11. Related Reports
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Thermo Fisher Scientific Inc.
  • Proimmune ltd.
  • Laboratory Corporation Of America Holdings
  • Creative Biolabs and
  • Histogenetics LLC
  • THE UCLA immunogenetics center.
  • Admera Health
  • Quick Biology
  • NEW YORK blood center
  • The Sequencing Center
  • Bloodcenter of Wisconsin
  • Thermo Fisher Scientific Inc.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll